• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    RAPT Therapeutics, Inc. - Common Stock (NQ:RAPT)

    10.68 +0.19 (+1.81%)
    Streaming Delayed Price Updated: 2:10 PM EDT, Aug 4, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 18,157
    Open 10.50
    Bid (Size) 10.59 (1)
    Ask (Size) 10.74 (1)
    Prev. Close 10.49
    Today's Range 10.49 - 10.89
    52wk Range 5.666 - 26.56
    Shares Outstanding 34,358,152
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    There are notable gap-ups and gap-downs in today's session.
    Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session. 
    Via Chartmill
    RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -18.1%
    -18.1%
    1 Month
    +30.9%
    +30.9%
    3 Month
    +46.1%
    +46.1%
    6 Month
    +17.1%
    +17.1%
    1 Year
    -50.7%
    -50.7%

    More News

    Read More
    RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position
    Via Stocktwits
    Topics ETFs
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    RAPT Therapeutics to Participate in Upcoming Investor Conferences
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    RAPT Therapeutics Reports First Quarter 2025 Financial Results
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    RAPT Therapeutics to Participate in Upcoming Investor Conferences
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    Futures Slide As Bond Yields Jump To 6 Month High
    Via Talk Markets
    Topics Bonds Commodities Cryptocurrencies
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why RAPT Therapeutics Stock Gained Over 100% On Monday?
    Via Benzinga
    US Stocks Mixed, Dow Tumbles 150 Points
    Via Benzinga
    Topics Stocks
    RAPT Therapeutics Announces $150 Million Private Placement
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    RAPT Therapeutics Reports Third Quarter 2024 Financial Results
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga

    Frequently Asked Questions

    Is RAPT Therapeutics, Inc. - Common Stock publicly traded?
    Yes, RAPT Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does RAPT Therapeutics, Inc. - Common Stock trade on?
    RAPT Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for RAPT Therapeutics, Inc. - Common Stock?
    The ticker symbol for RAPT Therapeutics, Inc. - Common Stock is RAPT on the Nasdaq Stock Market
    What is the current price of RAPT Therapeutics, Inc. - Common Stock?
    The current price of RAPT Therapeutics, Inc. - Common Stock is 10.68
    When was RAPT Therapeutics, Inc. - Common Stock last traded?
    The last trade of RAPT Therapeutics, Inc. - Common Stock was at 08/04/25 02:10 PM ET
    What is the market capitalization of RAPT Therapeutics, Inc. - Common Stock?
    The market capitalization of RAPT Therapeutics, Inc. - Common Stock is 366.95M
    How many shares of RAPT Therapeutics, Inc. - Common Stock are outstanding?
    RAPT Therapeutics, Inc. - Common Stock has 367M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.